Bronchial carcinoid tumors: A retrospective analysis of 126 patients (original) (raw)

Abstract

cases of primary carcinoma of the lung were diagnosed at the Duke University Medical Center. During the same period, 126 patients (mean age, 53 f 13 years) were diagnosed with bronchial carcinoid. The overall survival was 78% for 5 years and 71% for 10 years. Surgical treatment in 106 patients included pneumonectomy (15), lobectomy (63 with 9 bronchoplastic procedures), stapled wedge resection (221, and bronchoscopic laser resection (6). The method of diagnosis was chest roentgenography (1211, chest computed tomography (77), mediastinal tomography (31), bronchoscopy (Sl), bronchoscopic brushing and washing (501, bronchoscopic biopsy (40), transthoracic needle biopsy (271, thoracotomy (loo), and autopsy (5). Univariate analysis of the medical history, presenting signs and symptoms, diagnostic test results, and pathologic data predicted improved survival (p < 0.001) for: female sex (n = 581, lthough bronchial carcinoid tumors were described A in the 1800s, it was Seigfreid Oberndorfer [l] who coined the term Karzinoide or "resembling carcinoma" in 1907. In 1930, Kramer grouped carcinoid tumors with cylindromas as bronchial adenomas because of their good prognosis compared with bronchogenic carcinoma. It later became apparent that there was a subset of carcinoid adenomas that were more aggressive and therefore were designated as "atypical" by Arrigoni and associates [3] in 1972. Over the last 30 years, several series of bronchial carcinoid tumors have appeared in the literature, but none of substantial size has described this clinical entity in detail with an emphasis on univariate and multivariate survival analysis in the modern era of immunocytochemistry, electron microscopy, and chemotherapy. asymptomatic presentation (n := 47), normal serum serotonin or urinary hydroxyindoleacetic acid levels (n = 76), peripheral location of the primary tumor (n = 50), pathologic stage I or I1 (n = 91), negative lymph nodes (n = 80), primary tumor 2 cm or less in diameter (n = 671, and typical histology (n = 80). No significance ( p > 0.1) was

Key takeaways

sparkles

AI

  1. The study analyzed 126 patients with bronchial carcinoid tumors, emphasizing survival rates and surgical outcomes.
  2. Five-year survival is 95% for pathologic stage I disease, indicating excellent prognosis post-resection.
  3. Factors predicting improved survival include pathologic stage, atypical histology, and asymptomatic presentation.
  4. No significant correlations were found for age, smoking history, or environmental exposure affecting carcinoid tumor formation.
  5. This series represents one of the largest analyses of atypical carcinoids, contributing valuable survival data.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (35)

  1. Oberndorfer S. Karzinoide. Ergebnisse der allgemeinen Pa- thologie und pathologischen Anatomie des Menschen und der Tiere. 1909;13:527-35.
  2. Kramer R. Adenoma of bronchus. Ann Otol Rhino1 Laryngol 1930;39:689-75.
  3. Arrigoni MG, Woolner LB, Bernatz PE. Atypical carcinoid tumors of the lung. J Thorac Cardiovasc Surg 1972;64:413-7.
  4. Kaplan EL, Meier P. Nonparametric estimation from incom- plete observation. J Am Stat Assoc 1958;53:457-81.
  5. Cox DR. Regression models and life tables. J R Stat SOC [B] 1972;34:187-200.
  6. Laennec RTH. Traite de l'auscultation mediate et des mala- dies des poumons et du coeur. Vol 1. Third edition. Paris: Chaude, 1831:250.
  7. Decaro LF, Paladugu R, Benfield JR, et al. Typical and atypical carcinoids within the pulmonary APUD tumor spec- trum. J Thorac Cardiovasc Surg 1983;86:528-36.
  8. Okike N, Bernatz PE, Woolner LB. Carcinoid tumors of the lung. Ann Thorac Surg 1976;22:270-7.
  9. Paladugu RR, Benfield JR, Pak HY, Ross RK, Teplitz RL. Bronchopulmonary Kulchitzy cell carcinoma. Cancer 1985;55: 1303-11.
  10. Stamatis G, Freitag L, Greschuchna D. Limited and radical resection for tracheal and bronchopulmonary carcinoid tu- mour: report on 227 cases. Eur J Cardiothorac Surg 1990;4: 527-33.
  11. Greenberg RS, Buamgarten DA, Clark WS, et al. Prognostic factors for gastrointestinal and bronchopulmonary carcinoid tumors. Cancer 1987;60:2476-83.
  12. Godwin DJ. Carcinoid tumors. Cancer 1974;36:560-9.
  13. McCaughan BC, Martini N, Bains MS. Bronchial carcinoids.
  14. Zeitels J, Naunheim K, Kaplan EL, Straus F. Carcinoid
  15. Mirtensson H, Bottcher G, Hambraeus G, Sundler F, Willen J Thorac Cardiovasc Surg 1985;89:8-17. tumors. Arch Surg 1982;117732-7.
  16. DR SIBU P. SAHA (Lexington, KY): Dr Harpole, I enjoyed your presentation. This is an excellent review on the topic of bronchial carcinoid tumor. For the last 10 years, we have seen a total of 32 carcinoid tumors in our practice. During that same period, we saw a little more than 3,000 lung cancers. This is a relatively rare tumor. In our group, there were 4 patients with atypical carcinoid tumor. All of them died within 12 to 18 months of their diagnosis. I would like to ask you about the histologic features of tests that H, Nobin A. Bronchial carcinoids: an analysis of 91 cases. World J Surg 1987;11:356-64.
  17. Dawes L, Schulte WJ, Condon RE. Carcinoid tumors. Arch Surg 1984;119:375-8.
  18. Bertelsen S, Lund C, Badsberg E, et al. Bronchial carcinoid tumours. Scand J Thorac Cardiovasc Surg 1985;19:105-11.
  19. Hurt R, Bates M. Carcinoid tumours of the bronchus: a 33 year experience. Thorax 1984;39:617-23.
  20. Todd TR, Cooper JD, Weissberg D, et al. Bronchial carcinoid tumors: twenty years' experience. J Thorac Cardiovasc Surg 1980;79:532-6.
  21. Warren WH, Gould VE, Faber LP, et al. Neuroendocrine neoplasms of the bronchopulmonary tract. J Thorac Cardio- vasc Surg 1985;89:819-25.
  22. Wilkins EW Jr, Grillo HC, Moncure AC, Scannell JG. Chang- ing times in surgical management: management of bron- chopulmonary carcinoid tumor. Ann Thorac Surg 1984;38: 33944.
  23. Rea F, Binda R, Spreafico G , et al. Bronchial carcinoids: a review of 60 patients. Ann Thorac Surg 1989;47:412-4.
  24. Diaz-Jimenez JI' , Canela-Cardona M, Maestre-Alcacer J. Nd: YAG laser photo-resection of low-grade malignant tumors of the tracheobronchial tree. Chest 1990;97920-2.
  25. Cavaliere S, Foccoli P, Farina PL. Nd:YAG laser bronchos- copy: a five-year experience with 1,396 applications in 1,000 patients. Chest 1988;94:15-21.
  26. Bomanji J, Levison DA, Zuzarte J, Britton KE. Imaging of carcinoid tumors with iodine-123 metaiodobenzylguanidine. J Nucl Med 1987;28:1907-10.
  27. Hoefnagel CA, Jager dH, Taal BG, Abeling NGGM, Engels- man EE. The role of I-131-MIBG in the diagnosis and therapy of carcinoids. Eur J Nucl Med 1987;13:187-91.
  28. Troncone L, Rufini V, Monteniaggi P, Danza FM, Lasorella A, Mastrangelo R. The diagnostic and therapeutic utility of radioiodinated metaiodobenzylguanidine (MIBG). Eur J Nucl Med 1990;16:325-35.
  29. Moertel CG, Rubin J, Kvols LK. Therapy of metastatic carcinoid tumor and the malignant carcinoid syndrome with recombinant leukocyte A interferon. J Clin Oncol 1989;7 865-8.
  30. Valimaki M, Jarvinen H, Salmela P, et al. Is the treatment of metastatic carcinoid tumor with interferon not as successful as suggested? Cancer 1991;67547-9.
  31. Schupak KD, Wallner KE. The role of radiation therapy in the treatment of locally unresectable or metastatic carcinoid tu- mors. Int J Radiat Oncol Biol Phys 1991;20:489-95.
  32. Kvols LK. Metastatic carcinoid tumors and the carcinoid syndrome: a selective review of chemotherapy and hormonal therapy. Am J Med 1986;81:49-55.
  33. Kvols LK, Buck M. Chemotherapy of metastatic carcinoid and islet cell tumors. Am J Med 1987;82:77-83.
  34. Jodrell DI, Smith IE. Carboplatin in the treatment of meta- static carcinoid tumours and paraganglioma: a phase I1 study. Cancer Chemother Pharmacol 1989;26:624.
  35. Kvols LK, Moertel CG, OConnell MJ, et al. Treatment of the malignant carcinoid syndrome: evaluation of a long-acting somatostatin analogue. N Engl J Med 1987;315:663-6.